Oppenheimer Asset Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-23,498
| Closed | -$393K | – | 1139 |
|
|
2020
Q2 | $393K | Buy |
23,498
+331
| +1% | +$5.54K | 0.01% | 853 |
|
|
2020
Q1 | $334K | Sell |
23,167
-520
| -2% | -$7.5K | 0.01% | 839 |
|
|
2019
Q4 | $793K | Buy |
23,687
+6,477
| +38% | +$217K | 0.02% | 689 |
|
|
2019
Q3 | $360K | Buy |
17,210
+10,252
| +147% | +$214K | 0.01% | 887 |
|
|
2019
Q2 | $145K | Sell |
6,958
-1,107
| -14% | -$23.1K | ﹤0.01% | 1134 |
|
|
2019
Q1 | $180K | Buy |
8,065
+3,255
| +68% | +$72.6K | ﹤0.01% | 1064 |
|
|
2018
Q4 | $115K | Buy |
+4,810
| New | +$115K | ﹤0.01% | 1158 |
|